Literature DB >> 15313298

Therapeutic application of tissue plasminogen activator for fibrin reaction after cataract surgery.

Filiz Ozveren1, Kadir Eltutar.   

Abstract

PURPOSE: To evaluate the efficacy and safety of therapeutic application of recombinant tissue plasminogen activator (rtPA) for fibrin reaction after uneventful cataract surgery.
SETTING: Department of Ophthalmology, SSK Istanbul Hospital, Istanbul, Turkey.
METHOD: In a prospective study between January and June 2000, 26 eyes of 26 patients with fibrin reaction after uneventful cataract surgery received 3 microg of intracameral rtPA. Patients were evaluated for recurrences of fibrin reaction or complications by slitlamp biomicroscopy 2, 12, and 24 hours, 1 week, and 1 and 6 months after rtPA application. Intraocular pressure (IOP) was measured by Goldmann applanation tonometry. Visual acuity was tested using a standard Snellen chart 1 week after rtPA application.
RESULTS: All 26 eyes had complete fibrinolysis. Three eyes (11.5%) had corneal edema that lasted fewer than 24 hours. Visual acuity improved by 0 to 7 lines in 19 patients (73.1%). No patient had an increase in IOP. At 6 months, no patient had hyphema or recurrence of fibrin reaction.
CONCLUSIONS: Complete lysis of fibrin after cataract surgery with conventional topical medications can take a long time and is not successful in some patients. Intracameral application of 3 microg rtPA was an efficient, safe method for the treatment of fibrin reaction after cataract surgery.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15313298     DOI: 10.1016/j.jcrs.2004.02.042

Source DB:  PubMed          Journal:  J Cataract Refract Surg        ISSN: 0886-3350            Impact factor:   3.351


  4 in total

1.  Reduction of steroid-induced intraocular pressure elevation in sheep by tissue plasminogen activator.

Authors:  Rosana Gerometta; Sandeep Kumar; Shaily Shah; Larry Alvarez; Oscar Candia; John Danias
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-12-03       Impact factor: 4.799

2.  Tissue plasminogen activator reduces the elevated intraocular pressure induced by prednisolone in sheep.

Authors:  Oscar A Candia; Rosana M Gerometta; John Danias
Journal:  Exp Eye Res       Date:  2014-10-07       Impact factor: 3.467

3.  Intraocular Lens Opacification following Intracameral Injection of Recombinant Tissue Plasminogen Activator to Treat Inflammatory Membranes after Cataract Surgery.

Authors:  Simon S M Fung; Evripidis Sykakis; Niaz M Islam; Hadi J Zambarakji; Ramin Khoramnia; Gerd U Auffarth; Dipak N Parmar
Journal:  J Ophthalmol       Date:  2015-03-18       Impact factor: 1.909

4.  Successful pediatric DMEK facilitated by intracameral tissue plasminogen activator to mitigate anterior chamber fibrin reaction.

Authors:  Tanner J Ferguson; Elias I Traboulsi; Jeffrey M Goshe
Journal:  Am J Ophthalmol Case Rep       Date:  2020-06-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.